From the last 100 to the first 100-outcome after a manufacturer change in reverse fracture arthroplasty
- PMID: 39833337
- PMCID: PMC11753307
- DOI: 10.1007/s00068-024-02724-3
From the last 100 to the first 100-outcome after a manufacturer change in reverse fracture arthroplasty
Abstract
Purpose: If surgery is indicated for elderly patients suffering a proximal humerus fracture, reverse fracture arthroplasty became the preferred type of treatment due to its good and reliable outcomes over the last decade. Surgeons could choose from a wide range of implants and up to now there was no evaluation, if a change of the manufacturer affects patients` outcome.
Methods: The last 100 patients before and the first 100 after manufacturer change in reverse fracture arthroplasty were evaluated at a level one trauma center, all treated by only 3 senior shoulder surgeons. Clinical as well as radiographic outcome parameters were assessed, perioperative up to 24 months after surgery.
Results: Mean age in both groups was nearly 80 years with comparable distribution of gender and comorbidities. A trend to shorter duration of surgery was observed after the change, mainly according to an uncemented fixation of the stem. During follow-up no significant differences, beneficial as well as negative, could be observed regarding clinical and radiographic outcome.
Conclusion: A manufacturer change on the fly is possible without negative consequences for patients` outcome. Expertise of the whole OR-team as well as standardized training with the new implant seems to be a more important factor than a specific type of implant.
Keywords: Elderly; Manufacturer; Ortho-geriatric; Reverse fracture arthroplasty.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Conflict of interests: All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by Johannes Gleich and Tobias Helfen. The first draft of the manuscript was written by Johannes Gleich and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Figures




References
-
- Somerson JS, Hsu JE, Neradilek MB, Matsen FA 3rd. Analysis of 4063 complications of shoulder arthroplasty reported to the US Food and Drug Administration from 2012 to 2016. J Shoulder Elbow Surg. 2018;27(11):1978–86. - PubMed
-
- Dieter C, Wirtz MDM, EWK,. DRG’s in Orthopädie und Unfallchirurgie. Berlin, Heidelberg: Springer; 2013.
-
- Constant CR, Murley AH. A clinical method of functional assessment of the shoulder. Clin Orthop Relat Res. 1987;214(1):160–4. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical